8,296 Shares in DaVita Inc. (NYSE:DVA) Bought by Arjuna Capital

Arjuna Capital purchased a new position in DaVita Inc. (NYSE:DVA - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 8,296 shares of the company's stock, valued at approximately $1,269,000.

A number of other hedge funds also recently modified their holdings of DVA. UMB Bank n.a. raised its holdings in shares of DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares during the period. Copia Wealth Management bought a new stake in DaVita during the 4th quarter valued at $30,000. Coppell Advisory Solutions LLC raised its holdings in DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after acquiring an additional 100 shares during the period. Canada Post Corp Registered Pension Plan bought a new stake in DaVita during the 4th quarter valued at $55,000. Finally, Jones Financial Companies Lllp raised its holdings in DaVita by 28.6% during the 4th quarter. Jones Financial Companies Lllp now owns 517 shares of the company's stock valued at $77,000 after acquiring an additional 115 shares during the period. Institutional investors own 90.12% of the company's stock.

Analysts Set New Price Targets

DVA has been the topic of a number of analyst reports. Truist Financial lowered their target price on shares of DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a report on Monday, May 19th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, DaVita currently has a consensus rating of "Hold" and an average price target of $164.50.

DaVita Price Performance

Shares of DaVita stock traded down $1.03 during trading on Friday, hitting $142.43. The stock had a trading volume of 537,608 shares, compared to its average volume of 812,048. The firm has a market cap of $10.75 billion, a price-to-earnings ratio of 14.12, a P/E/G ratio of 0.98 and a beta of 1.11. DaVita Inc. has a 12 month low of $131.76 and a 12 month high of $179.60. The business's 50-day moving average is $140.24 and its 200 day moving average is $148.91. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.25. The firm had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.22 billion. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The business's quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.26 earnings per share. As a group, sell-side analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.